Local Recurrence vs Radiotherapy-Induced Edema in Advanced Laryngeal Carcinoma: Is FDG PET/CT Up to the Challenge?

ISSN: 2211-5544 (Online)
ISSN: 2211-5552 (Print)

Volume 4, 2 Issues, 2015

Download PDF Flyer

Current Molecular Imaging (Discontinued)

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Abass Alavi
Department of Radiology/Nuclear Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA 19104
Email: abass.alavi@uphs.upenn.edu

View Full Editorial Board

Purchase Articles Order Reprints

Local Recurrence vs Radiotherapy-Induced Edema in Advanced Laryngeal Carcinoma: Is FDG PET/CT Up to the Challenge?

Current Molecular Imaging (Discontinued), 2(2): 158-163.

Author(s): Sagi Tshori, Martine Klein, Jeffrey Weinberger, Roland Chisin and Nanette Freedman.

Affiliation: Chairman, Department of Medical Biophysics and Nuclear Medicine, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel 91120.


Head-and-neck squamous cell carcinoma (HNSCC) is a high-risk disease. Historically, treatment often involved mutilating surgery, with devastating implications for quality of life, particularly in patients with advanced-stage laryngeal squamous cell carcinoma (ALSCC). Treatment for ALSCC always included total laryngectomy. Nowadays, treatment with more effective chemoradiotherapy regimes in newly diagnosed patients may often avoid total laryngectomy; however recurrence rates are relatively high. Techniques for early identification of recurrence or residual disease have therefore become crucial. Clinical diagnosis by laryngoscopy is problematic; radiotherapy induced laryngeal edema, which may persist for years, can mask local disease, resulting in detection at a late stage when total laryngectomy is unavoidable.

F18-2-fluoro-2-deoxy-D-glucose (FDG) PET/CT has emerged as an excellent imaging tool in the diagnosis and follow-up of HNSCC patients. In this review, we discuss experience with FDG PET/CT for follow-up of ALSCC after radiotherapy. While there is a high negative predictive value for FDG PET/CT in this situation, as in other HNSCC cases, a high rate of false positive findings in the larynx is described. Increased FDG uptake may be due to ongoing inflammation in the region of persistent edema, and may result in repeated laryngeal biopsies, with potentially deleterious long-term consequences.

FDG PET/CT is an efficient imaging modality for the diagnosis and follow-up of HNSCC patients, but has limitations in the follow-up of ALSCC post-radiotherapy—benefits and risks must be weighed with caution.


Advanced laryngeal carcinoma, FDG PET/CT, post-radiotherapy edema.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 2
Issue Number: 2
First Page: 158
Last Page: 163
Page Count: 6
DOI: 10.2174/22115552113029990010
Price: $58

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science